25314599|t|Synthesis and biological evaluation of novel curcuminoid derivatives.
25314599|a|Curcuminoids have been reported to possess multiple bioactivities, such as antioxidant, anticancer and anti-inflammatory properties. Three novel series of curcuminoid derivatives (11a-h, 15a-h and 19a-d) with enhanced bioactivity have been synthesized. Among the synthesized compounds, 11b exhibited the most significant activity with an MIC of 0.5 microM /mL against selected medically important Gram-positive cocci (S. aureus and S. viridans) and Gram-negative bacilli (E. coli and E. cloacae). The derivatives exhibited remarkable results in an antioxidant test with an IC50 2.4- to 9.3-folder smaller than curcuminoids. With respect to antiproliferative activity against Hep-G2, LX-2, SMMC7221 and MDA-MB-231, the derivatives exhibited an effect stronger than curcuminoids with an IC50 ranging from 0.18 to 4.25 microM. 
25314599	45	56	curcuminoid	Chemical	MESH:D036381
25314599	70	82	Curcuminoids	Chemical	MESH:D036381
25314599	178	190	inflammatory	Disease	MESH:D007249
25314599	225	236	curcuminoid	Chemical	MESH:D036381
25314599	250	255	11a-h	Chemical	-
25314599	257	262	15a-h	Chemical	-
25314599	267	272	19a-d	Chemical	-
25314599	356	359	11b	Chemical	-
25314599	488	497	S. aureus	Species	
25314599	502	513	S. viridans	Species	78535
25314599	542	549	E. coli	Species	562
25314599	554	564	E. cloacae	Species	550
25314599	680	692	curcuminoids	Chemical	MESH:D036381
25314599	745	751	Hep-G2	CellLine	CVCL:0027
25314599	753	757	LX-2	CellLine	CVCL:5792
25314599	759	767	SMMC7221	CellLine	CVCL:0534
25314599	772	782	MDA-MB-231	CellLine	CVCL:0062
25314599	834	846	curcuminoids	Chemical	MESH:D036381
25314599	Negative_Correlation	MESH:D036381	MESH:D007249

